NCBVX | VMVAX | NCBVX / VMVAX | |
Total Expense Ratio | 1.95 | 0.07 | 2,786% |
Annual Report Gross Expense Ratio | 2.81 | 0.07 | 4,014% |
Fund Existence | 27 years | 14 years | - |
Gain YTD | 4.800 | 5.198 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 163M | 31B | 1% |
Annual Yield % from dividends | 1.00 | 2.22 | 45% |
Returns for 1 year | 7.61 | 7.67 | 99% |
Returns for 3 years | 15.61 | 17.51 | 89% |
Returns for 5 years | 82.80 | 65.15 | 127% |
Returns for 10 years | 24.99 | 87.87 | 28% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FCGPX | 20.78 | 0.04 | +0.19% |
NYLI PineStone Global Equity Class P | |||
FLUAX | 28.39 | -0.06 | -0.21% |
Fidelity Advisor Stk Selec Lg Cp Val A | |||
SUVAX | 12.58 | -0.05 | -0.40% |
PGIM Quant Solutions Large-Cap Val A | |||
LSSIX | 29.00 | -0.12 | -0.41% |
Loomis Sayles Small Cap Growth Instl | |||
PRVIX | 53.38 | -0.23 | -0.43% |
T. Rowe Price Small-Cap Value I |